⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL5369991 | 0.98 | TP53 (0.51) | — | |
| Bromide SCHEMBL28919507 | 0.98 | TP53 (0.51) | — | |
| Hydrochloric Acid SCHEMBL27472182 | 0.98 | TP53 (0.51) | — | |
| SCHEMBL15125278 | 0.81 | TP53 (0.42) | — | |
| SCHEMBL28300836 | 0.79 | — | — | |
| SCHEMBL1720771 | 0.79 | KDM4E (0.46) | — | |
| SCHEMBL9016443 | 0.79 | TP53 (0.42) | — | |
| SCHEMBL8180918 | 0.79 | TP53 (0.45) | — | |
| SCHEMBL1829342 | 0.79 | TP53 (0.42) | — | |
| SCHEMBL5164308 | 0.77 | TP53 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 597 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110234635-A | Novel substituted benzimidazole derivatives as D-amino oxidase (DAAO) inhibitors | 宇凤·简·曾 | 2019-09-13 | — | — | CN | claimed |
| CN-110191882-A | Novel heterocyclic compounds, preparation method and the pharmaceutical composition comprising it | 株式会社大熊制药 | 2019-08-30 | — | — | CN | claimed |
| CN-105980365-B | Benzimidazol-2-amines as mIDH1 inhibitors | 拜耳医药股份公司 | 2019-06-21 | — | — | CN | claimed |
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | BASF SE (DE) | 2019-03-05 | — | — | US | claimed |
| US-20170012208-A1 | ORGANIC SEMICONDUCTOR FORMULATIONS | USINVEST LLC | 2017-01-12 | — | — | US | claimed |
| CN-105980365-A | Benzimidazol-2-amines as mIDH1 inhibitors | 拜耳医药股份公司 | 2016-09-28 | — | — | CN | claimed |
| CN-102050816-A | Method for synthesizing olmesartan medoxomil | BEIJING VENTUREPHARM MEDICAL TECHNOLOGY CO LTD | 2011-05-11 | — | — | CN | claimed |
| CN-101198594-A | Process for the production of intermadiates for the preparation of tricyclic benzimidazoles | NYCOMED GMBH (DE) | 2008-06-11 | — | — | CN | claimed |
| CN-100393720-C | Cyclic benzimidazoles. | ALTANA PHARMA AG (DE) | 2008-06-11 | — | — | CN | claimed |
| WO-2007148344-A2 | PROCESS FOR THE PREPARATION OF OLMESARTAN MEDOXOMIL | MATRIX LABORATORIES LIMITED (IN) | 2007-12-27 | — | — | WO | claimed |
| CN-1893941-A | Fused-ring compounds and use thereof as drugs | JAPAN TOBACCO INC (JP) | 2007-01-10 | — | — | CN | claimed |
| CN-1167680-C | fused ring compound and pharmaceutical use thereof | �ձ��̲ݲ�ҵ��ʽ���� | 2004-09-22 | — | — | CN | claimed |
| EP-1450795-A1 | PEPTIDE ISOSTERES CONTAINING A HETEROCYCLE USEFUL IN THE TREATMENT OF ALZHEIMER'S DISEASE | Elan Pharmaceuticals, Inc. (US) | 2004-09-01 | — | — | EP | claimed |
| WO-2003047576-A1 | PEPTIDE ISOSTERES CONTAINING A HETEROCYCLE USEFUL IN THE TREATMENT OF ALZHEIMER'S DISEASE | ELAN PHARMACEUTICALS, INC. (US) | 2003-06-12 | — | — | WO | claimed |
| EP-4743465-A1 | BICYCLIC MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE | F. Hoffmann-La Roche AG (CH) | 2026-05-20 | — | — | EP | disclosed |
| US-12617789-B2 | Small molecular inhibitors of NF-κb inducing kinase | JANSSEN PHARMACEUTICA NV (BE) | 2026-05-05 | — | — | US | disclosed |
| US-20260115174-A1 | PHARMACOLOGICAL CORRECTORS OF RHODOPSIN AND USES THEREOF | OCTANT INC (US) | 2026-04-30 | — | — | US | disclosed |
| CN-87101880-A | METHOD FOR CONTROLLING WEEDS | — | 1987-09-23 | — | — | CN | disclosed |
| CN-87100994-A | 1H-Imidazole-5-carboxylic acid derivatives | — | 1987-09-09 | — | — | CN | disclosed |
| CN-86104173-A | The preparation method of novel 5-imidazolyl carboxylic acid derivative and their use | — | 1987-01-28 | — | — | CN | disclosed |